| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005792-200005000-00003 |
| P698 | PubMed publication ID | 10844935 |
| P50 | author | Harry Malech | Q42654598 |
| P2093 | author name string | S M Holland | |
| J I Gallin | |||
| S J Chanock | |||
| R H Buckley | |||
| J Boyle | |||
| J A Winkelstein | |||
| R B Johnston | |||
| H Ochs | |||
| J Curnutte | |||
| C B Foster | |||
| H Dickler | |||
| M C Marino | |||
| P Quie | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 155-169 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Chronic granulomatous disease. Report on a national registry of 368 patients | |
| P478 | volume | 79 |
| Q34390072 | 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host |
| Q52645694 | A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004-2017). |
| Q40350822 | A Female Neonate Presenting With Fever and Rash |
| Q40661603 | A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients |
| Q64106977 | A Novel Mutation in Chronic Granulomatous Disease: Treating the Family, Not Just the Patient |
| Q90706579 | A Novel Mutation in the NCF2 Gene in a CGD Patient With Chronic Recurrent Pneumopathy |
| Q42284632 | A Pink Milk Bottle Mystery |
| Q45874911 | A Review of Chronic Granulomatous Disease |
| Q36495858 | A case of chronic granulomatous disease with a necrotic mass in the bronchus: a case report and a review of literature |
| Q24803510 | A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-gamma |
| Q34363036 | A case report of chronic granulomatous disease presenting with aspergillus pneumonia in a 2-month old girl |
| Q82375538 | A death from Langerhans cell histiocytosis and tuberculosis in 18th Century Hungary - what palaeopathology can tell us today |
| Q24594813 | A decade of Burkholderia cenocepacia virulence determinant research |
| Q35990085 | A history of pediatric immunology |
| Q33319574 | A model of Salmonella colitis with features of diarrhea in SLC11A1 wild-type mice |
| Q37381703 | A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. |
| Q33246026 | A nonribosomal peptide synthetase (Pes1) confers protection against oxidative stress in Aspergillus fumigatus |
| Q31036756 | A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease |
| Q99609592 | A novel mutation in CYBB induced X-linked chronic granulomatous disease: A case report |
| Q40393561 | A novel mutation in NCF1 in an adult CGD patient with a liver abscess as first presentation |
| Q34995959 | A practical approach to neutrophil disorders. |
| Q57518087 | A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning |
| Q37190119 | A role for NADPH oxidase in antigen presentation. |
| Q38654282 | A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis |
| Q35105573 | A virtual infection model quantifies innate effector mechanisms and Candida albicans immune escape in human blood |
| Q33921729 | Acidomonas methanolica-associated necrotizing lymphadenitis in a patient with chronic granulomatous disease |
| Q35646990 | Actinomyces and nocardia infections in chronic granulomatous disease |
| Q33909306 | Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. |
| Q34958427 | Advances in Burkholderia cepacia complex |
| Q45880406 | Advances in treatment for chronic granulomatous disease |
| Q36525556 | Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity |
| Q35093986 | Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience |
| Q90534605 | Altered Humoral Immune Responses and IgG Subtypes in NOX2-Deficient Mice and Patients: A Key Role for NOX2 in Antigen-Presenting Cells |
| Q39768422 | Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD). |
| Q34108392 | Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus |
| Q35591440 | An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease |
| Q40144448 | An Infant with Prolonged Fever. |
| Q58576039 | An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection |
| Q39166302 | An emerging role for neutrophil extracellular traps in noninfectious disease |
| Q40483430 | An interaction between Scribble and the NADPH oxidase complex controls M1 macrophage polarization and function |
| Q37902456 | An outbreak of Burkholderia cepacia complex associated with intrinsically contaminated nasal spray |
| Q43702831 | An unusual case of sarcoidosis |
| Q33276690 | An unusual cause of granulomatous disease. |
| Q43744169 | An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease |
| Q50146070 | Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A). |
| Q34450506 | Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice |
| Q35210323 | Antimicrobial actions of reactive oxygen species |
| Q34009631 | Antioxidant enzyme expression in clinical isolates of Pseudomonas aeruginosa: identification of an atypical form of manganese superoxide dismutase |
| Q64917259 | Application of Flow Cytometry in Primary Immunodeficiencies: Experience From India. |
| Q24801432 | Arthritis and osteomyelitis due to Aspergillus fumigatus: a 17 years old boy with chronic granulomatous disease |
| Q47645142 | Aspergillosis in Chronic Granulomatous Disease. |
| Q26864717 | Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction |
| Q43087816 | Aspergillus species identification in the clinical setting. |
| Q34362345 | Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy |
| Q34338562 | Assembly of the phagocyte NADPH oxidase |
| Q34650014 | Assessment of atherosclerosis in chronic granulomatous disease |
| Q38784163 | Association Between Discoid Lupus Erythematosus and Chronic Granulomatous Disease--Report of Two Cases and Review of the Literature. |
| Q37595906 | Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice |
| Q43254303 | Atypical presentation of chronic granulomatous disease in an adolescent boy with frontal lobe located Aspergillus abscess mimicking intracranial tumor. |
| Q42780624 | Atypical presentation of chronic granulomatous disease with Burkholderia cepacia |
| Q24307761 | Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation |
| Q37174792 | B-cell activating factor (BAFF) is elevated in chronic granulomatous disease |
| Q43609427 | BCGiosis as a presenting feature of a child with chronic granulomatous disease |
| Q34404618 | Biochemical hematology of platelets and leukocytes. |
| Q55951449 | Biotechnological Applications of Acetic Acid Bacteria |
| Q27673736 | Burkholderia cenocepacia BC2L-C Is a Super Lectin with Dual Specificity and Proinflammatory Activity |
| Q37064461 | Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology |
| Q42912568 | Burkholderia glumae infection in an infant with chronic granulomatous disease. |
| Q56940690 | Burkholderia pseudomallei infection in chronic granulomatous disease |
| Q90664239 | C-rac-king the Code of Smoke-induced Pneumonia Susceptibility |
| Q33719919 | CD36 deficiency attenuates experimental mycobacterial infection. |
| Q35098244 | CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans |
| Q46751148 | CYBB, an NADPH-oxidase gene: restricted diversity in humans and evidence for differential long-term purifying selection on transmembrane and cytosolic domains |
| Q34237335 | Canadian clinical practice guidelines for invasive candidiasis in adults |
| Q36393828 | Case 1: The formula dance |
| Q34258663 | Cellular aspects of Burkholderia cepacia infection |
| Q26865114 | Cervical lymph node diseases in children |
| Q46636174 | Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease |
| Q45147432 | Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease |
| Q58785705 | Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils |
| Q34390535 | Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis |
| Q82651120 | Child and caregiver psychosocial functioning in pediatric immunodeficiency disorders |
| Q43694070 | Chinese patients with defective IL-12/23-interferon-gamma circuit in Taiwan: partial dominant interferon-gamma receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor beta1 mutation as pneumatocele. |
| Q36187935 | Chromobacterium Violaceum Sepsis: Rethinking Conventional Therapy to Improve Outcome |
| Q51226978 | Chronic Granulomatous Disease Due to Neutrophil Cytosolic Factor (NCF2) Gene Mutations in Three Unrelated Families. |
| Q55259171 | Chronic Granulomatous Disease First Diagnosed in Adulthood Presenting With Spinal Cord Infection. |
| Q33553834 | Chronic Granulomatous Disease Presenting as Aspergillus Fumigatus Pneumonia in a Previously Healthy Young Woman. |
| Q40270325 | Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France |
| Q53261887 | Chronic Granulomatous Disease. |
| Q36057408 | Chronic Granulomatous Disease: A Large, Single-center US Experience |
| Q58412751 | Chronic Granulomatous Disease: Two Decades of Experience From a Tertiary Care Centre in North West India |
| Q27009322 | Chronic granulomatous disease |
| Q82085363 | Chronic granulomatous disease |
| Q82797426 | Chronic granulomatous disease |
| Q84018615 | Chronic granulomatous disease |
| Q45004674 | Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. |
| Q80260413 | Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase |
| Q42225641 | Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds |
| Q34394453 | Chronic granulomatous disease presenting as aseptic ascites in a 2-year-old child |
| Q35747331 | Chronic granulomatous disease presenting as refractory pneumonia in late adulthood. |
| Q51799416 | Chronic granulomatous disease with unusual clinical manifestation, outcome, and pattern of inheritance in an Iranian family. |
| Q45391987 | Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment. |
| Q30335769 | Chronic granulomatous disease. |
| Q40517468 | Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients |
| Q38672968 | Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects. |
| Q38148008 | Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece |
| Q35084276 | Chronic granulomatous disease: a review of the infectious and inflammatory complications |
| Q34644316 | Chronic granulomatous disease: lessons from a rare disorder |
| Q35098193 | Chronic granulomatous disease: overview and hematopoietic stem cell transplantation |
| Q21143799 | Chronic granulomatous disease: the European experience |
| Q50749489 | Chronic granulomatous disease: two members of a single family with different dermatologic manifestations. |
| Q34502590 | Chronic granulomatous disease: why an inflammatory disease? |
| Q30235499 | Clinical Features and Genetic Analysis of 48 Patients with Chronic Granulomatous Disease in a Single Center Study from Shanghai, China (2005-2015): New Studies and a Literature Review. |
| Q40725842 | Clinical and Genotypic Spectrum of Chronic Granulomatous Disease in 71 Latin American Patients: First Report from the LASID Registry |
| Q38961320 | Clinical and imaging considerations in primary immunodeficiency disorders: an update |
| Q45252471 | Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients |
| Q88108603 | Clinical and molecular features of 38 children with chronic granulomatous disease in mainland china |
| Q83275094 | Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center |
| Q34421458 | Clinical disease caused by Klebsiella in 2 unrelated patients with interleukin 12 receptor beta1 deficiency |
| Q46706752 | Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan |
| Q38146948 | Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease |
| Q39325613 | Clinical, Immunological, and Molecular Findings of Patients with p47(phox) Defect Chronic Granulomatous Disease (CGD) in Indian Families |
| Q99585991 | Clinical, functional and genetic characterization of Sixteen Patients Suffering from Chronic Granulomatous Disease variants - Identification of Eleven Novel Mutations in CYBB |
| Q42961300 | Cloning and characterization of a sialidase from the filamentous fungus, Aspergillus fumigatus |
| Q36765485 | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. |
| Q37346342 | Color me bad: microbial pigments as virulence factors |
| Q35992729 | Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets |
| Q38255586 | Common dermatologic manifestations of primary immune deficiencies |
| Q35451854 | Common severe infections in chronic granulomatous disease |
| Q37240590 | Common variable immunodeficiency: a new look at an old disease. |
| Q35019838 | Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis |
| Q33552027 | Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases |
| Q36897336 | Concomitant use of corticosteroid and antimicrobials for liver abscesses in patients with chronic granulomatous disease |
| Q92487347 | Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders |
| Q54215574 | Considerations in the Diagnosis of Chronic Granulomatous Disease. |
| Q44213444 | Construction of a deep-rough mutant of Burkholderia cepacia ATCC 25416 and characterization of its chemical and biological properties |
| Q43270760 | Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency |
| Q34508425 | Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. |
| Q35151721 | Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease |
| Q38068957 | Crohn's as an immune deficiency: from apparent paradox to evolving paradigm. |
| Q39013210 | Curative haploidentical BMT in a murine model of X-linked chronic granulomatous disease. |
| Q35131029 | Current concepts of hyperinflammation in chronic granulomatous disease |
| Q73329305 | Cut it out: Managing hepatic abscesses in patients with chronic granulomatous disease |
| Q36730748 | Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology |
| Q36161489 | Cutaneous signs of neonatal and infantile immunodeficiency |
| Q38216460 | Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies |
| Q39028574 | Cytokines IL-17 and IL-22 in the host response to infection |
| Q38473221 | Deep pyoderma caused by Burkholderia cepacia complex associated with ciclosporin administration in dogs: a case series |
| Q34497865 | Defective acute inflammation in Crohn's disease: a clinical investigation |
| Q40538212 | Dental infections as a cause of persistent fever in a patient with chronic granulomatous disease |
| Q36670949 | Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease |
| Q82605242 | Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S) |
| Q33849142 | Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease |
| Q37238684 | Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency |
| Q28359854 | Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease |
| Q37008250 | Differences in enzymatic properties allow SodCI but not SodCII to contribute to virulence in Salmonella enterica serovar Typhimurium strain 14028 |
| Q33706275 | Differential diagnosis in ulcerative colitis in an adolescent: Chronic granulomatous disease needs extra attention. |
| Q35106470 | Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis |
| Q78705444 | Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases |
| Q50088722 | Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. |
| Q38986684 | Disseminated infections with antibiotic-resistant non-typhoidal Salmonella strains: contributions of host and pathogen factors |
| Q45736804 | Disseminated nocardiosis in a patient with X-linked chronic granulomatous disease and human immunodeficiency virus infection |
| Q38067482 | Do X-linked diseases affect periodontal health? |
| Q91596752 | Downregulation of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in a co-culture system with human stimulated X-linked CGD neutrophils |
| Q41678910 | Dramatic Improvement in the Multifocal Positron Emission Tomography Findings of a Young Adult with Chronic Granulomatous Disease Following Allogeneic Hematopoietic Stem Cell Transplantation |
| Q41486625 | Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation. |
| Q55403581 | Emerging Role of D-Amino Acid Metabolism in the Innate Defense. |
| Q36944944 | Emericella quadrilineata as cause of invasive aspergillosis |
| Q79851951 | Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B |
| Q38078251 | Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis. |
| Q38668190 | Enzymatic Mechanisms Involved in Evasion of Fungi to the Oxidative Stress: Focus on Scedosporium apiospermum |
| Q41996461 | Epidemiology of Invasive Fungal Disease in Children |
| Q36835086 | Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes |
| Q33761211 | European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). |
| Q36949421 | Examining the use of ICD-9 diagnosis codes for primary immune deficiency diseases in New York State |
| Q45874973 | Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease |
| Q44960585 | Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene |
| Q90700440 | Familial Celiac Disease Remission as a Result of a Full Donor Immunologic Recovery After Sibling Cord Blood Transplantation for Chronic Granulomatous Disease: A Case Report |
| Q53138834 | Familial Chronic Granulomatous Disease Affecting Three Siblings and Causing Recurrent Tuberculosis. |
| Q43294590 | Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease |
| Q40574361 | Fever and leg pain in a 42-month-old |
| Q40558083 | Fever, abdominal pain, and interstitial pneumonia in a 13-year-old female |
| Q46362922 | Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs. |
| Q28293120 | First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families |
| Q28076919 | Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies |
| Q44914759 | Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia |
| Q59636304 | Frequency and Clinical Manifestations of Patients with Primary Immunodeficiency Disorders in Iran: Update from the Iranian Primary Immunodeficiency Registry |
| Q41986433 | Fulminant mulch pneumonitis in undiagnosed chronic granulomatous disease: a medical emergency. |
| Q40441305 | Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. |
| Q36951255 | Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs. |
| Q40520761 | Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells |
| Q36841586 | Fungal infections in primary immunodeficiencies |
| Q45866380 | Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease |
| Q28072810 | Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD) |
| Q88651319 | Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases |
| Q40347373 | Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy. |
| Q34469023 | Gastrointestinal and hepatic manifestations of primary immune deficiency diseases |
| Q37209760 | Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. |
| Q36592663 | Gastrointestinal manifestations of chronic granulomatous disease |
| Q59351801 | Gene expression in chronic granulomatous disease and interferon-γ receptor-deficient cells treated in vitro with interferon-γ |
| Q90383791 | Gene therapy and genome editing for primary immunodeficiency diseases |
| Q33406944 | Gene therapy for PIDs: progress, pitfalls and prospects |
| Q34419791 | Gene therapy for inherited immunodeficiency |
| Q38364511 | Gene therapy for primary immunodeficiencies. |
| Q34473374 | Gene therapy of chronic granulomatous disease: the engraftment dilemma |
| Q35184193 | Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox). |
| Q40482541 | Genetic Phagocyte NADPH Oxidase Deficiency Enhances Nonviable Candida albicans-Induced Inflammation in Mouse Lungs. |
| Q40446101 | Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease. |
| Q36330018 | Genetic Susceptibility to Fungal Infections in Humans |
| Q37183884 | Genetic Susceptibility to Fungal Infections: What is in the Genes? |
| Q37417920 | Genetic analysis of 10 unrelated Korean families with p22-phox-deficient chronic granulomatous disease: an unusually identical mutation of the CYBA gene on Jeju Island, Korea |
| Q61807040 | Genetic and Clinical Profiles of Disseminated Bacillus Calmette-Guérin Disease and Chronic Granulomatous Disease in China |
| Q37136614 | Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo |
| Q37045234 | Genetic immunodeficiency diseases |
| Q38537340 | Genetic susceptibility to invasive Salmonella disease |
| Q35569570 | Genetic variation and hematology: single-nucleotide polymorphisms, haplotypes, and complex disease |
| Q89630891 | Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease |
| Q50557087 | Genetical analysis of all Danish patients diagnosed with chronic granulomatous disease. |
| Q37176109 | Genetics and immunopathology of chronic granulomatous disease |
| Q34992223 | Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease |
| Q97541937 | Granulomatous diseases: Oral manifestations and recommendations |
| Q47615252 | Haploidentical hematopoietic stem cell transplantation for a case with X-linked chronic granulomatous disease |
| Q40226730 | Haploinsufficiency of NADPH Oxidase Subunit Neutrophil Cytosolic Factor 2 Is Sufficient to Accelerate Full-Blown Lupus in NZM 2328 Mice |
| Q37487733 | Hematopoetic stem cell transplantation in neutrophil disorders: severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous disease |
| Q38752164 | Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders. |
| Q92802115 | Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives |
| Q43812773 | Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease |
| Q57908242 | Hepatic abnormalities in patients with chronic granulomatous disease |
| Q34554404 | Hepatic abscess in patients with chronic granulomatous disease |
| Q36933346 | High Intracellular Concentrations of Posaconazole Do Not Impact on Functional Capacities of Human Polymorphonuclear Neutrophils and Monocyte-Derived Macrophages In Vitro |
| Q40641312 | High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients. |
| Q44293200 | High glucose impairs superoxide production from isolated blood neutrophils |
| Q24633510 | High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease |
| Q43411970 | High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost-effective method for screening molecular defects: four novel mutations found in X-linked chronic granulomatous disease |
| Q57523148 | Histopathological features of chronic granulomatous disease (CGD) in childhood |
| Q34571742 | Hodgkin lymphoma in 2 children with chronic granulomatous disease |
| Q50073021 | Host response to pulmonary fungal infections: A highlight on cell-driven immunity to Cryptococcus species and Aspergillus fumigatus. |
| Q37340368 | Host specificity of bacterial pathogens |
| Q40333903 | How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases |
| Q37842628 | How has neutrophil research improved our understanding of periodontal pathogenesis? |
| Q24672245 | How neutrophils kill microbes |
| Q35965043 | Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae |
| Q34100373 | Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. |
| Q89986135 | Human inborn errors of immunity underlying superficial or invasive candidiasis |
| Q38837849 | Hyper-responsive Toll-like receptor 7 and 9 activation in NADPH oxidase-deficient B lymphoblasts |
| Q37176113 | Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase |
| Q38195246 | ICON: the early diagnosis of congenital immunodeficiencies |
| Q37627905 | IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans |
| Q40245006 | IL-20 Signaling in Activated Human Neutrophils Inhibits Neutrophil Migration and Function. |
| Q61701708 | Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91phox resulting in the rare X91+ variant of chronic granulomatous disease |
| Q33831618 | Identification of a Novel Mutation in the CYBB Gene, p.Asp378Gly, in a Patient With X-linked Chronic Granulomatous Disease |
| Q64448924 | Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain |
| Q101476394 | Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999-2018) |
| Q33357120 | Immune deficiency and autoimmunity |
| Q39076987 | Immunity to Commensal Fungi: Detente and Disease |
| Q36729350 | Immunity to microbes: lessons from primary immunodeficiencies. |
| Q37626121 | Immunodeficiencies |
| Q34994477 | Immunodeficiency and genetic conditions that cause arthritis in childhood |
| Q35129044 | Immunomodulation of invasive fungal infections |
| Q37116947 | Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4 |
| Q35136916 | Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-γ in a nitric oxide-dependent manner |
| Q46263244 | Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals |
| Q38904301 | Incidence of typically Severe Primary Immunodeficiency Diseases in Consanguineous and Non-consanguineous Populations |
| Q42513243 | Increased neutrophil oxidative burst metabolism in systemic lupus erythematosus |
| Q38552989 | Infantile Fistula-in-Ano: A Report of Two Patients and Review for Dermatologists |
| Q40279058 | Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India |
| Q38048847 | Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression |
| Q35558806 | Infections in Patients with Inherited Defects in Phagocytic Function |
| Q43470644 | Infections with Haemophilus species in chronic granulomatous disease: insights into the interaction of bacterial catalase and H2O2 production |
| Q61727903 | Infectious Complications in Patients With Chronic Granulomatous Disease |
| Q37056322 | Inflammatory manifestations in chronic granulomatous disease (CGD). |
| Q30425441 | Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis |
| Q47854983 | Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease |
| Q61053904 | Inherited p40phox deficiency differs from classic chronic granulomatous disease |
| Q22252859 | Innate immunity in inflammatory bowel disease: a disease hypothesis |
| Q34587177 | Innate immunity to Mycobacterium tuberculosis |
| Q37940665 | Insights into human antifungal immunity from primary immunodeficiencies. |
| Q88691581 | Integrative Physiology of Pneumonia |
| Q33916216 | Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea |
| Q36250853 | Interstitial lung disease in a patient with chronic granulomatous disease |
| Q33909352 | Invasive aspergillosis due to Neosartorya udagawae |
| Q37955638 | Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey |
| Q43263590 | Janus-Faced Neutrophil Extracellular Traps in Periodontitis. |
| Q43796232 | Keratitis caused by Candida glabrata in a patient with chronic granulomatous disease |
| Q35011464 | Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates |
| Q38835840 | LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus |
| Q36753685 | Lack of p47(phox) in Akita Diabetic Mice Is Associated with Interstitial Pneumonia, Fibrosis, and Oral Inflammation |
| Q39561887 | Lentiviral Vector Gene Therapy Protects XCGD Mice From Acute Staphylococcus aureus Pneumonia and Inflammatory Response. |
| Q92979235 | Lentiviral gene therapy for X-linked chronic granulomatous disease |
| Q38195200 | Lentiviral vectors for the treatment of primary immunodeficiencies |
| Q35778617 | Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease. |
| Q43779609 | Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections |
| Q34182786 | Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease |
| Q35408185 | Lipid- and polymer-based drug delivery carriers for eradicating microbial biofilms causing medical device-related infections. |
| Q34429033 | Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice |
| Q35789900 | Long polymerase chain reaction-based fluorescence in situ hybridization analysis of female carriers of X-linked chronic granulomatous disease deletions. |
| Q50104585 | Long-term follow-up and prognosis of chronic granulomatous disease in Yugoslavia: is there a role for early bone marrow transplantation? |
| Q40526315 | Long-term interferon-gamma therapy for patients with chronic granulomatous disease |
| Q35553610 | Long-term outcome of patients with p22 (phox) -deficient chronic granulomatous disease on Jeju Island, Korea |
| Q41353450 | Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease |
| Q33703196 | Lupus and proliferative nephritis are PAD4 independent in murine models. |
| Q35673745 | Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase |
| Q37577712 | Making sense of the cause of Crohn's - a new look at an old disease |
| Q39684886 | Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease |
| Q50093392 | Mastoidectomy in a child with chronic granulomatous disease. |
| Q28066193 | Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies |
| Q34792962 | Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection. |
| Q49923802 | Mechanisms to Evade the Phagocyte Respiratory Burst Arose by Convergent Evolution in Typhoidal Salmonella Serovars. |
| Q27022250 | Mendelian genetics of human susceptibility to fungal infection |
| Q26862947 | Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity |
| Q36906968 | Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood |
| Q27336723 | Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis |
| Q37064440 | Modern management of chronic granulomatous disease |
| Q38950276 | Modern management of phagocyte defects |
| Q47334511 | Modulating Host Signaling Pathways to Promote Resistance to Infection by Candida albicans |
| Q90322108 | Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues |
| Q33654713 | Molecular analysis of X-linked chronic granulomatous disease in five unrelated Korean patients |
| Q37273205 | Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome |
| Q36965983 | Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease |
| Q37974983 | Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome |
| Q30538643 | Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. |
| Q38911356 | Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD. |
| Q36372960 | Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis |
| Q64231080 | Mucormycotic Osteomyelitis Involving the Maxilla: A Rare Case Report and Review of the Literature |
| Q37224540 | Multiple pericardial abscesses in a child with known chronic granulomatous disease |
| Q44318186 | Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. |
| Q90066827 | Munchausen syndrome mimicking refractory subcutaneous abscess with bacteremia, diagnosed by repetitive element sequence-based polymerase chain reaction: a case report |
| Q53545782 | Mutations of chronic granulomatous disease in Turkish families. |
| Q36517880 | Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease |
| Q49422978 | NADPH Oxidase Deficiency: A Multisystem Approach. |
| Q37713391 | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis |
| Q36302873 | NADPH oxidases: an overview from structure to innate immunity-associated pathologies |
| Q36647903 | NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury |
| Q35977261 | NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation? |
| Q33840366 | NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome |
| Q42264626 | NOX2 protects against prolonged inflammation, lung injury, and mortality following systemic insults. |
| Q33911333 | NOX2-dependent regulation of inflammation |
| Q37601820 | Necrotizing Liver Granuloma/Abscess and Constrictive Aspergillosis Pericarditis with Central Nervous System Involvement: Different Remarkable Phenotypes in Different Chronic Granulomatous Disease Genotypes. |
| Q40052231 | Neutrophil Evolution and Their Diseases in Humans |
| Q54261956 | Neutrophil-generated HOCl leads to non-specific thiol oxidation in phagocytized bacteria. |
| Q49570630 | Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system. |
| Q38221176 | Neutrophils at work |
| Q28087227 | Neutrophils: Between host defence, immune modulation, and tissue injury |
| Q27002519 | New insights into innate immune control of systemic candidiasis |
| Q55282167 | New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma. |
| Q36698099 | Newly diagnosed chronic granulomatous disease in a 44 year old male presenting with recurrent groin cellulitis and colitis |
| Q46682211 | Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn disease |
| Q40126607 | Nine patients with chronic granulomatous disease having selective neck dissection for severe cervical lymphadenitis. |
| Q34141669 | Nocardia infection in chronic granulomatous disease |
| Q38078056 | Non-Aspergillus fungal infections in chronic granulomatous disease |
| Q55021826 | Noninfectious Manifestations and Complications of Chronic Granulomatous Disease. |
| Q38167633 | Ocular involvement in primary immunodeficiency diseases |
| Q38363105 | Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies |
| Q33531937 | Orofacial findings in chronic granulomatous disease: report of twelve patients and review of the literature |
| Q33851299 | Osteomyelitis and lung abscess due to Aspergillus fumigatus in a chronic granulomatous disease patient |
| Q37880202 | Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature |
| Q37304752 | Otitis media as a presenting complaint in childhood immunodeficiency diseases |
| Q33357224 | Otolaryngologic manifestations of immunodeficiency |
| Q37684019 | Otolaryngologic manifestations of pediatric immunodeficiency |
| Q35030912 | Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting |
| Q60907100 | Oxidative Stress in Poultry: Lessons from the Viral Infections |
| Q33715508 | Oxidative stress in the pathology and treatment of systemic lupus erythematosus |
| Q34238532 | P67-phox (NCF2) lacking exons 11 and 12 is functionally active and leads to an extremely late diagnosis of chronic granulomatous disease (CGD) |
| Q47913800 | Paecilomyces formosus Infection in an Adult Patient with Undiagnosed Chronic Granulomatous Disease |
| Q38916325 | Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital's 5-Year Experience. |
| Q35227431 | Peculiarities of cell death mechanisms in neutrophils. |
| Q34584769 | Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease |
| Q73293990 | Perceptions of reproductive risk and carrier testing among adolescent sisters of males with chronic granulomatous disease |
| Q37161242 | Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase |
| Q38373915 | Phagocyte NADPH oxidase and specific immunity |
| Q35027263 | Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GN |
| Q37141844 | Phagocyte dysfunction and inflammatory bowel disease |
| Q33420369 | Phagocytic superoxide specifically damages an extracytoplasmic target to inhibit or kill Salmonella |
| Q34141420 | Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration |
| Q33840702 | Phellinus tropicalis abscesses in a patient with chronic granulomatous disease |
| Q26825944 | Pneumococcal vaccine and patients with pulmonary diseases |
| Q38798358 | Polymorphonuclear neutrophils in periodontitis and their possible modulation as a therapeutic approach |
| Q28306873 | Population prevalence of diagnosed primary immunodeficiency diseases in the United States |
| Q43708431 | Posaconazole for treatment of refractory invasive fungal disease. |
| Q34532546 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America |
| Q29042159 | Practice parameter for the diagnosis and management of primary immunodeficiency |
| Q48653640 | Preimplantation genetic diagnosis for HLA typing in a case of X-linked chronic granulomatous disease. |
| Q58735127 | Preliminary study on chronic granulomatous disease in Sri Lanka |
| Q50084357 | Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections. |
| Q36763235 | Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007. |
| Q44832666 | Prevalence of chronic granulomatous disease in pediatric patients diagnosed with Crohn's disease |
| Q54973296 | Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease. |
| Q56941015 | Primary Immune Deficiencies Presenting in Adults: Seven Years of Experience from Iran |
| Q97067634 | Primary Immunodeficiencies With Defects in Innate Immunity: Focus on Orofacial Manifestations |
| Q62658778 | Primary Immunodeficiency Diseases in Latin America: The Second Report of the LAGID Registry |
| Q39027692 | Primary immune deficiencies with defects in neutrophil function. |
| Q33902831 | Primary immunodeficiencies underlying fungal infections |
| Q36371000 | Primary immunodeficiency diseases in oman: five years' experience at sultan qaboos university hospital |
| Q34114555 | Primary phagocytic disorders of childhood |
| Q56941385 | Propionibacterium acnes Chest Infections in Patients with Chronic Granulomatous Disease: Case Reports |
| Q57173966 | Prédisposition mendélienne aux infections mycobactériennes et défaut de l’explosion oxydative des macrophages |
| Q40216978 | Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils. |
| Q45400331 | Psychrobacter immobilis septicemia in a boy with X-linked chronic granulomatous disease and fulminant hepatic failure |
| Q36996797 | Pulmonary Aspergillosis in a Previously Healthy 13-Year-Old Boy. |
| Q35674223 | Pulmonary complications of primary immunodeficiencies |
| Q38079835 | Pulmonary manifestations of chronic granulomatous disease |
| Q36973074 | Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation. |
| Q33813874 | Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting |
| Q40200333 | Rare diagnosis in a neonate who presents with fever |
| Q38851117 | Reactive oxygen homeostasis - the balance for preventing autoimmunity. |
| Q36593591 | Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections. |
| Q37098488 | Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia |
| Q24624942 | Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease |
| Q90383809 | Recent advances in chronic granulomatous disease |
| Q38119863 | Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review |
| Q40059524 | Recent advances in understanding and treating chronic granulomatous disease |
| Q41929675 | Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children. |
| Q34429384 | Recognizing primary immune deficiency in clinical practice |
| Q30435963 | Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center |
| Q34132929 | Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease |
| Q46085453 | Recurrent streptococcal hepatic abscesses in a 46-year-old woman |
| Q43640569 | Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study |
| Q37247851 | Redundant hydrogen peroxide scavengers contribute to Salmonella virulence and oxidative stress resistance. |
| Q36040945 | Regulation of innate immunity by NADPH oxidase |
| Q60300625 | Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin |
| Q34832611 | Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies |
| Q89440609 | Renal Disease in Chronic Granulomatous Disease: Data from the USIDNET Registry |
| Q40429733 | Renal amyloidosis in a child with chronic granulomatous disease and invasive aspergillosis |
| Q41614325 | Renal transplantation in a patient with chronic granulomatous disease: case report |
| Q36410497 | Residual NADPH oxidase activity and isolated lung involvement in x-linked chronic granulomatous disease |
| Q28301969 | Residual NADPH oxidase and survival in chronic granulomatous disease |
| Q54290737 | Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease. |
| Q37372812 | Restoration of NET formation by gene therapy in CGD controls aspergillosis |
| Q35568541 | Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial |
| Q33387329 | Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils |
| Q47133379 | Review: Metabolic Control of Immune System Activation in Rheumatic Diseases |
| Q37349116 | Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders |
| Q39140136 | Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy |
| Q33864943 | Role of NADPH oxidase in host defense against aspergillosis |
| Q34098141 | Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense |
| Q33552201 | Role of Protein Kinase C and Nox2-Derived Reactive Oxygen Species Formation in the Activation and Maturation of Dendritic Cells by Phorbol Ester and Lipopolysaccharide. |
| Q39299815 | Role of apoptosis and autophagy in tuberculosis |
| Q52733597 | Role of gp91phox in hepatic macrophage programming and alcoholic liver disease. |
| Q35217529 | Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice |
| Q34862986 | Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection. |
| Q36521306 | SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans |
| Q50043378 | Salmonella detoxifying enzymes are sufficient to cope with the host oxidative burst. |
| Q34611825 | Salmonella evades D-amino acid oxidase to promote infection in neutrophils. |
| Q24610283 | Serologic reactivity to the emerging pathogen Granulibacter bethesdensis |
| Q90259713 | Serum Biomarkers for Early Diagnosis of Chinese X-CGD Children: Case Reports and a Literature Review |
| Q54572514 | Severe X-linked chronic granulomatous disease in two unrelated females. |
| Q37226837 | Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft |
| Q34489893 | Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease |
| Q30303140 | Single amino acid substitution in homogentisate 1,2-dioxygenase is responsible for pigmentation in a subset of Burkholderia cepacia complex isolates |
| Q57121572 | Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency |
| Q38113986 | Skin manifestations of primary immune deficiency |
| Q37426267 | Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease |
| Q24655272 | Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry |
| Q47166455 | Spectrum of imaging findings of chronic granulomatous disease: a single center experience |
| Q37107790 | Spectrum of primary immune deficiency at a tertiary care hospital |
| Q93645648 | Spoken sessions |
| Q39534623 | Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease. |
| Q91900034 | Staphylococcus aureus Lipoic Acid Synthesis Limits Macrophage Reactive Oxygen and Nitrogen Species Production To Promote Survival during Infection |
| Q39037945 | Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease |
| Q38735833 | Stem cell transplantation for the treatment of immunodeficiency in children: current status and hopes for the future |
| Q46871937 | Stem-cell transplantation for chronic granulomatous disease |
| Q38984645 | Study of naïve and memory cells in a cohort of Egyptian chronic granulomatous disease patients. |
| Q40896765 | Subclinical intestinal inflammation in chronic granulomatous disease patients |
| Q41534196 | Subcutaneous abscess due to the basidiomycete Phellinus mori in a patient with chronic granulomatous disease |
| Q39809887 | Subspecialty evaluation of chronically ill hospitalized patients with suspected immune defects |
| Q64100149 | Successful application of next-generation sequencing for pre-natal diagnosis in a pedigree with chronic granulomatosis disease |
| Q33606830 | Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report |
| Q46936602 | Successful renal transplantation in patients with chronic granulomatous disease |
| Q46788388 | Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation |
| Q36244604 | Successful treatment of fungal osteomyelitis with voriconazole in a patient with chronic granulomatous disease |
| Q51682318 | Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease. |
| Q43703233 | Successful unrelated bone marrow transplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis |
| Q48370654 | Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation |
| Q42113918 | Superoxide production and expression of NAD(P)H oxidases by transformed and primary human colonic epithelial cells |
| Q84446170 | Suppurative lymphadenitis |
| Q35070983 | Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease |
| Q35608083 | Systemic lupus erythematosus-associated neutrophil cytosolic factor 2 mutation affects the structure of NADPH oxidase complex |
| Q37962982 | Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century |
| Q33743570 | Th17 cytokines and the gut mucosal barrier |
| Q49960282 | The Changing Paradigm of Management of Liver Abscesses in Chronic Granulomatous Disease. |
| Q35851420 | The Endoplasmic Reticulum Stress Sensor Inositol-Requiring Enzyme 1α Augments Bacterial Killing through Sustained Oxidant Production |
| Q50181582 | The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. |
| Q37204038 | The NADPH oxidase NOX2 plays a role in periodontal pathologies |
| Q59326775 | The Plasma Membrane: A Platform for Intra- and Intercellular Redox Signaling |
| Q36635676 | The Relationship Between Invasive Nontyphoidal Salmonella Disease, Other Bacterial Bloodstream Infections, and Malaria in Sub-Saharan Africa |
| Q46349699 | The Role of NrF2 in the Regulation of Periodontal Health and Disease |
| Q34052242 | The blessings and curses of intestinal inflammation |
| Q37962986 | The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment |
| Q42688094 | The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils |
| Q37825925 | The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes |
| Q34454572 | The immunologic workup of the child suspected of immunodeficiency |
| Q37783925 | The many roles of NOX2 NADPH oxidase-derived ROS in immunity |
| Q36531751 | The role of Candida albicans AP-1 protein against host derived ROS in in vivo models of infection. |
| Q89181533 | The role of neutrophil extracellular traps in rheumatic diseases |
| Q33904653 | The role of neutrophils and NETosis in autoimmune and renal diseases |
| Q90266811 | The role of neutrophils in host defense against invasive fungal infections |
| Q36759569 | The role of surgery in the management of patients with refractory chronic granulomatous disease colitis |
| Q34786696 | The role of the gut flora in health and disease, and its modification as therapy |
| Q36872083 | The role of the innate immune system in granulomatous disorders |
| Q37722665 | Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells. |
| Q38920756 | Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience. |
| Q41994928 | Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease. |
| Q36942513 | Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies |
| Q39941137 | Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. |
| Q41994355 | Transition From Pediatric to Adult Care by Young Adults With Chronic Granulomatous Disease: The Patient's Viewpoint. |
| Q54347197 | Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. |
| Q38048853 | Treatment of candidiasis: insights from host genetics |
| Q43252991 | Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC. |
| Q87696079 | Two Chronic Granulomatous Disease Diagnosed in Adult Age |
| Q40289910 | Two siblings with prolonged fever and pneumonia |
| Q33716493 | USIDNET: a strategy to build a community of clinical immunologists |
| Q36006149 | Ulcerative colitis associated with chronic granulomatous disease: case report |
| Q36480989 | Umbilical cord stem cell transplantation for primary immunodeficiencies |
| Q37135419 | Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies. |
| Q33410503 | Undiagnosed Chronic Granulomatous Disease, Burkholderia cepacia complex Pneumonia, and Acquired Hemophagocytic Lymphohistiocytosis: A Deadly Association |
| Q34310579 | Urinary tract infection by chromobacterium violaceum |
| Q52575536 | Use of Genetic Testing for Primary Immunodeficiency Patients. |
| Q39093281 | Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions. |
| Q36560699 | Utility of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in a child with chronic granulomatous disease |
| Q82535300 | Utility of screening for chronic granulomatous disease in patients with inflammatory bowel disease |
| Q50092440 | Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET). |
| Q38212512 | Vaccine use in primary immunodeficiency disorders |
| Q89848736 | Variable Presentation of the CYBB Mutation in One Family, Approach to Management, and a Review of the Literature |
| Q41987460 | Very Early-Onset Inflammatory Manifestations of X-Linked Chronic Granulomatous Disease |
| Q38430977 | Very early-onset inflammatory bowel disease: gaining insight through focused discovery |
| Q30436584 | Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease |
| Q64950468 | X-Linked Chronic Granulomatous Disease: Initial Presentation with Intracranial Hemorrhage from Vitamin K Deficiency in Infant. |
| Q37008479 | X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation |
| Q35841384 | Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. |
| Q83367731 | [Primary immune deficiencies in neutrophil functioning] |
| Q37073789 | p47phox deficiency induces macrophage dysfunction resulting in progressive crystalline macrophage pneumonia |
Search more.